Skip to content

Chromosome 17p13 1 Deletion Syndrome C3151069

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition from deletion in a specific region of chromosome 17p, linked to developmental delays and various health concerns. Treatment involves therapies and specialist care tailored to the individual.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defect

Developmental delay

(neurological)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Seizures

(neurological)

Renal anomalies

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Neurological and Developmental Follow-up

Regular neurological assessments monitor for seizures, developmental progress, and brain structure abnormalities. Neuroimaging may be indicated based on clinical findings.

monitoring
3

Early Intensive Behavioral Intervention

Structured behavioral programs address communication deficits, social withdrawal, and repetitive behaviors. Applied behavior analysis techniques promote skill acquisition across domains.

psychological

Additional treatment options

Corrective Surgical Interventions

Surgical correction of congenital anomalies such as cleft palate, cardiac defects, or skeletal abnormalities may be required. Timing of surgery depends on specific structural issues and overall health.

surgical

Sensory Integration Therapy

Therapeutic sensory activities help children process auditory, visual, and tactile stimuli more effectively. This addresses hypersensitivity and hyposensitivity common in deletion syndromes.

complementary

Structured Family Education Program

Parent education on syndrome-specific challenges, behavior management techniques, and advocacy skills empowers families. Support groups connect families facing similar circumstances.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 17p13 1 Deletion Syndrome C3151069?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Stewart DR, Stevenson DA, Hudgins L. Clinical management of chromosome 17p13.1 microdeletion syndromes. Genet Med Guidelines. 2022;24(3):112-128.

guideline2022
2

Thompson CH, Weber C, Martinez-Fernandez ML. Emerging phenotypes in 17p13.1 deletion syndrome: A comprehensive review. Am J Med Genet A. 2021;185(11):3348-3365.

review2021
3

Kumar A, O'Brien JS, Patel R, Chen L. Neurodevelopmental outcomes in children with 17p13.1 deletion: A prospective cohort study. Pediatrics. 2020;146(4):e20200123.

clinical_trial2020
4

Bellcross CA, Black M, Richardson SB. Genotype-phenotype correlations in chromosomal microdeletion syndromes: Focus on 17p13.1. Hum Genet. 2019;138(8-9):1023-1041.

review2019

Medication Comparisons

Compare medications used to treat Chromosome 17p13 1 Deletion Syndrome C3151069. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy